Cargando…
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
The NeuMoDx HPV assay is a novel fully automated, real-time PCR-based assay for the qualitative detection of high-risk human papillomavirus (HPV) DNA in cervical specimens. The assay specifically identifies HPV16 and HPV18 and concurrently detects 13 other high-risk HPV types at clinically relevant...
Autores principales: | Heideman, Daniëlle A. M., Oštrbenk Valenčak, Anja, Doorn, Saskia, Bonde, Jesper, Hillemanns, Peter, Gimpelj Domjanič, Grega, Mlakar, Jana, Hesselink, Albertus T., Meijer, Chris J. L. M., Poljak, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143392/ https://www.ncbi.nlm.nih.gov/pubmed/35632634 http://dx.doi.org/10.3390/v14050893 |
Ejemplares similares
-
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test
por: Mostafa, Heba H., et al.
Publicado: (2020) -
Performance evaluation of NeuMoDx 96 system for hepatitis B and C viral load
por: Chooramani, Gagan, et al.
Publicado: (2023) -
Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay
por: Meletis, Georgios, et al.
Publicado: (2022) -
Cytomegalovirus Viral Load in Transplanted Patients Using the NeuMoDx™ (Qiagen) Automated System: A 1-Month Experience Feedback
por: Luciani, Léa, et al.
Publicado: (2021) -
Performance Evaluation of the Fully Automated NeuMoDx RT-PCR Platform for the Quantification of CMV and EBV DNA in EDTA Plasma: Implications for Clinical Management and Establishment of a Conversion Formula
por: Herdina, Anna Nele, et al.
Publicado: (2022)